Answers are grounded in this paper and cite their sources.
Background Sepsis remains a leading cause of morbidity and mortality worldwide and is characterized by a complex immune response that combine early hyperinflammation with prolonged immune dysfunction and increased susceptibility to secondary infections. Although numerous inflammatory and anti-inflammatory mediators have been implicated in this transition, the molecular mechanisms linking early protective responses to late immune paralysis remain incompletely understood. Recent evidence suggests that the nuclear IκB protein and transcriptional co-regulator IκBζ, encoded by the NFKBIZ gene, may occupy an important regulatory position in this process. Methods We discuss how persistent IκBζ expression may coordinate a transcriptional program characterized by continued production of interleukin-6 (IL-6), interleukin-10 (IL-10), and lipocalin-2 (LCN2), potentially contributing to prolonged STAT3 activation, macrophage tolerance, impaired antigen presentation, lymphocyte dysfunction, and susceptibility to secondary infection. We further examine the therapeutic implications of targeting IκBζ or STAT3 as upstream regulators capable of simultaneously modulating multiple downstream immunosuppressive pathways. Results IκBζ is rapidly induced downstream of pattern-recognition receptor signaling and selectively controls the expression of a subset of secondary response genes, including IL-6, IL-10, and LCN2, three mediators that exhibit dual protective and immunosuppressive functions during sepsis. Importantly, IL-6 and IL-10 are potent activators of STAT3, while emerging observations suggest that LCN2 can modulate STAT3-associated regulatory pathways through effects on iron homeostasis, cellular metabolism, and macrophage function. In turn, STAT3 has been shown to enhance IκBζ expression in non-sepsis experimental systems, establishing the potential for a self-reinforcing feed-forward regulatory circuit. Conclusions In this review, we propose that sustained activation of an IκBζ-STAT3 feed-forward loop provides a novel testable mechanistic model linking early inflammatory control and late-stage immunosuppression. This framework provides a mechanistic model for understanding the transition from hyperinflammation to immune paralysis and identifies the IκBζ-STAT3 axis as a potential therapeutic target in sepsis.
No takes yet. Share an insight, caveat, or question.
Cauvi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: